First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial

BACKGROUND: Salivary gland hypofunction and xerostomia are major complications following radiotherapy for head and neck cancer and may lead to debilitating oral disorders and impaired quality of life. Currently, only symptomatic treatment is available. However, mesenchymal stem cell (MSC) therapy ha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Grønhøj, Christian, Jensen, David H., Glovinski, Peter V., Jensen, Siri Beier, Bardow, Allan, Oliveri, Roberto S., Specht, Lena, Thomsen, Carsten, Darkner, Sune, Kiss, Katalin, Fischer-Nielsen, Anne, von Buchwald, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341429/
https://ncbi.nlm.nih.gov/pubmed/28270226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-1856-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados